Search results
Added:
1 week ago
In this Market Watch interview recorded at EuroPCR 2026 in Paris, Brad Wilson speaks with Dr Kendra Grubb, Chief Medical Officer for the structural heart team at Medtronic, about how transcatheter therapy is evolving across the aortic, mitral and tricuspid space.The discussion traces the maturation of TAVR from its early use in high-risk patients to today's wider device range and stronger…
View more
Start date:
Dec 03, 2024
Join us for an insightful webinar designed to enhance an understanding of the latest developments in pulmonary embolism (PE) management.Moderated by Prof Felix Mahfoud (University Hospital Basel, CH), the faculty will explore current guidelines with a critical eye, particularly where gaps may exist, such as in managing intermediate-risk patients. Featuring findings from the PEERLESS study, this…
View more
Added:
9 months ago
The ESC Congress 2025 symposium, “Transforming the Care of Female and Low-Risk Younger Patients With Aortic Stenosis Through Guidelines” is now available on demand.Chaired by Prof Stephan Windecker (Bern University Hospital, Bern, Switzerland) and Prof Vijay Kunadian (Newcastle University, Newcastle-upon-Tyne, UK), this session explores evolving strategies to optimise care for women and younger…
View more
Added:
3 months ago
Intracardiac echocardiography (ICE) has undergone a profound transformation in its role within left atrial appendage (LAA) closure – evolving from an experimental imaging adjunct to a clinically validated and increasingly adopted guidance strategy.In this on-demand educational discussion, Prof Jens Erik Nielsen-Kudsk (Aarhus University Hospital, DK) and Dr Sergio Berti (Fondazione Toscana G…
View more
Advancing Valve Care: An ESC 2025 Preview
Video Series
Added:
1 year ago
TIMELY is an integrated AI-based healthcare solution consisting of a certified physician platform and a patient app. It has been developed within an EU-funded project running from 2021 to 2025. TIMELY aims to assist both cardiac patients and their clinicians in personalising healthcare by evaluating risks and offering individualised exercise recommendations. The solution has been evaluated within…
View more
Added:
2 months ago
Source:
Interventional Cardiology Review Journal
For patients with atrial fibrillation (AF) at high risk for both stroke and bleeding, catheter-based left atrial appendage closure (LAAC) was not found to be non-inferior to physician-directed best medical care, according to the results of the CLOSURE-AF trial.¹MethodologyThe multicentre, randomised CLOSURE-AF trial was conducted in Germany to assess the effectiveness of LAAC compared with best…
View more
Added:
2 months ago
Source:
Interventional Cardiology Review Journal
Long-term follow-up from the FAMOUS-NSTEMI trial suggests that a fractional flow reserve-guided strategy for managing patients with non-ST-segment elevation myocardial infarction (NSTEMI) does not reduce adverse cardiovascular outcomes compared to standard angiography-guided care.¹MethodologyFAMOUS-NSTEMI was a prospective, randomised, controlled trial that enrolled 350 patients with NSTEMI…
View more
Start date:
Aug 07, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday…
View more
Supportive Care in Pulmonary Embolism
Added:
4 months ago
Review Article